Literature DB >> 12550113

Incomplete excision of basal cell carcinoma: a prospective multicentre audit.

P Kumar1, S Watson, A N Brain, P J Davenport, L J McWilliam, S S Banerjee, D L Bisset.   

Abstract

The audit of incomplete excision of basal cell carcinoma can be used as a parameter for clinical governance in plastic surgery units. However, there are no national standards, and all the previous reports from the UK have been retrospective and from regional units only. This 1 year prospective audit was undertaken simultaneously in the plastic surgery units of three different categories of hospital: a regional plastic surgery unit (University Hospital of South Manchester), a supraregional cancer hospital (Christie Hospital) and a district general hospital (Royal Bolton Hospital). A total of 757 lesions were excised from 600 patients, with 34 lesions (4.5%) being incompletely excised. The incidences of incomplete excision were similar in the regional unit (3.2%) and the district general hospital (3.1%), but higher in the supraregional cancer hospital (7.5%). The commonest site for incomplete excision was the eyebrow, followed by the postauricular area, the nose and the temple. There were no statistically significant differences in the distributions of the age and sex of the patients, the site and size of the lesions or the methods of repair between the three hospitals. However, there were significant differences in the distribution of syndromal, multiple and recurrent lesions, the grade of surgeon, and the clinical and histological subtypes. When the various confounding factors were adjusted by logistic regression, the variables most likely to have affected the incidence of incomplete excision were found to be grade of surgeon, minimal excision margin and histological subtype. Copyright 2002 The British Association of Plastic Surgeons. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12550113     DOI: 10.1054/bjps.2002.3948

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  8 in total

1.  Multivariate analysis of the influence of patient-, tumor-, and management-related factors on the outcome of surgical therapy for facial basal-cell carcinoma.

Authors:  Cornelia Katharina Mueller; Kristin Nicolaus; Michael Thorwarth; Stefan Schultze-Mosgau
Journal:  Oral Maxillofac Surg       Date:  2010-09

2.  Scalp Lesions Referred For Surgical Procedures: Single-Center 5-year Experience in Southwestern Poland.

Authors:  Iwona Chlebicka; Aleksandra A Stefaniak; Anna Gawdzik; Alicja RygaŁ; Łukasz Matusiak; Jacek C Szepietowski
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

3.  Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.

Authors:  Ki Woong Ro; Soo Hong Seo; Sang Wook Son; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

4.  Nonsurgical treatment options for Basal cell carcinoma.

Authors:  Mary H Lien; Vernon K Sondak
Journal:  J Skin Cancer       Date:  2011-01-09

Review 5.  Surgical treatment of basal cell carcinoma: an algorithm based on the literature.

Authors:  Flávio Barbosa Luz; Camila Ferron; Gilberto Perez Cardoso
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

6.  The illusion of conventional histological resection margin control.

Authors:  L C J van Delft; P J Nelemans; E van Loo; M Abdul Hamid; N W J Kelleners-Smeets
Journal:  Br J Dermatol       Date:  2019-01-18       Impact factor: 9.302

7.  Clinical and histopathological characteristics of primary and recurrent basal cell carcinoma: a retrospective study of the patients from a tertiary clinical centre in the northern Poland.

Authors:  Anna Płaszczyńska; Robert Skibiński; Martyna Sławińska; Wojciech Biernat; Aleksandra Lesiak; Roman J Nowicki; Michał Sobjanek
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

8.  Clinicopathological Factors Associated with Incomplete Excision of High-risk Basal Cell Carcinoma.

Authors:  Hannah Ceder; Annie Ekström; Lajla Hadzic; John Paoli
Journal:  Acta Derm Venereol       Date:  2021-07-13       Impact factor: 3.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.